Highland Therapeutics, Inc.
http://highlandtherapeutics.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Highland Therapeutics, Inc.
L’Oreal Defeats Slack-Fill Case In New York, Pivots To Clarisonic ‘Defect’ Complaint In California
L’Oreal USA beat a suit in May in New York regarding liquid cosmetics packaging, which plaintiffs alleged cheated consumers out of product they expected to be accessible, only to face a newly proposed class action, filed in California on 5 June, over an alleged Clarisonic waterproofing defect.
Ulta On Q1 COVID-19 Impact; ‘Illegal And Ineffective’ Hand Sanitizers In Europe; More Cosmetics News
Ulta Beauty says sales are roughly flat in the first 180 stores it reopened following the COVID-19 shutdown, which dragged down its net sales roughly 33% in the fiscal 2020 first quarter. More cosmetics news in brief.
Plaintiff Claims Against Beiersdorf For ‘Unlawfully Marketed Drug’ Are Preempted By FDCA, Court Rules
After five and a half years, three dismissal motions and one appeal, Beiersdorf’s prevailed on 15 April by summary judgment in a proposed class action alleging that its Nivea Skin Firming Hydration Body Lotion is an unlawfully marketed drug. Of course, the plaintiff still could appeal.
Beiersdorf’s Long Court Battle Over Nivea ‘Drug’ Claims May Be Ending; In Similar Case, L’Oreal May Settle
The Beiersdorf and L’Oreal cases, both pending in California federal courts, have important implications for the cosmetics industry and its use of benefit claims that test statutory boundaries between unapproved drug products and cosmetics.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice